Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.59 -1.05 (-0.86%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.13 PB Ratio: 1.76 GF Score: 85/100

Q2 2024 Jazz Pharmaceuticals PLC Earnings Call Transcript

Jul 31, 2024 / 08:30PM GMT
Release Date Price: $110.25 (-1.80%)
Editor

Please standby for streaming text.

Operator

I would like to welcome everyone to the GAAP earnings call. (Operator Instructions)

I would now like to turn the call over to Andrea Flynn, Vice President and Head of Investor Relations. You may begin.

Andrea Flynn
Jazz Pharmaceuticals PLC - Vice President, Head of Investor Relations

Thank you, operator, and good afternoon, everyone. Today, Jazz Pharmaceuticals reported second quarter of 23 and four financial results. Slide presentation accompanying this webcast is available on the Investors section of our website. Investors may also refer to the press release we issued earlier today, which is also posted to our website.

On the call today are Bruce Cozadd, jalapeno unto. I'd like to remind you that today's webcast includes forward-looking statements such as those related to our future financial and operating results, growth, potential in anticipated development and commercialization milestones and goals, which involve risks and uncertainties that could cause actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot